

Healthcare and biopharmaceutical leader with more than 20 years of experience spanning oncology, bone marrow transplant, pediatric hematology/oncology, and neurological rare diseases. Doctor of Nursing Practice–prepared clinician with extensive expertise in patient services, reimbursement support, patient education, and specialty therapy access across complex healthcare environments. Proven success supporting healthcare providers, gene therapy centers, and multidisciplinary care teams in navigating payer coverage, prior authorization, appeals, coding, and reimbursement pathways for HCP-administered therapies, including oncology and rare disease products.
Demonstrated leadership across regional, multi-state territories throughout Kentucky, Tennessee, Ohio, West Virginia, and Indiana, with deep experience collaborating cross-functionally to improve patient access, therapy initiation, adherence, and provider education. Successfully supported and launched multiple specialty and rare disease therapies, including disease-modifying therapies for Duchenne muscular dystrophy and spinal muscular atrophy. Recognized for translating strategic initiatives into operational execution through strong stakeholder engagement, clinical credibility, relationship-building, and solutions-oriented leadership.
Known for influencing healthcare professionals, payer stakeholders, and internal cross-functional partners through exceptional communication, accountability, and business acumen. Brings a strong track record of driving patient-centered outcomes, leading educational initiatives, supporting field-based operations, and fostering collaboration and leadership across commercial, clinical, and access functions.